Sign in to view content

2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

Nancy M. Holekamp, MD, FASRS

Video
Published 2018

Related

Survey of Intravitreal Injection Technique Among Retina Specialists in Mexico
Gabriela Lopezcarasa Hernandez, MD
On Demand Cases, Courses, and Papers
2021
Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results
Sam E. Mansour, MD, MSc,FACS, FRCS(C)
Annual Meeting Talks
2018
Progression of diabetic retinopathy in patients treated with 0.2 μg/day
Raymond Iezzi, MD, MS
Updates from the Field
2017

Category: Diabetic Retinopathy

See more